What's new

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 27, Status: Authorised

May 23, 2025 - 08:15
 0
Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

BYD outsells Tesla in Europe for the first time in April

Next Article

Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Da...

Related Posts

Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 11:00 (CEST) to 14 October 2025, 12:00 (CEST)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0